Bristol Myers Squibb reported $31.44B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
ALKERMES ALKS:US 1.05B 15.25M
Amgen AMGN:US $ 24380M 5281M
AstraZeneca AZN:LN 26.69B 583M
Astrazeneca AZN:US 26.69B 583M
Biogen BIIB:US $ 7162.3M 21.4M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Catalent CTLT:US $ 3931M 1013M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Drreddys Laboratories RDY:US $ 163272M 4496M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Lannett LCI:US $ 364.89M 11.33M
Medtronic MDT:US $ 22731M 297M
Novartis NOVN:VX 26.25B 2.45B
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Phibro Animal Health PAHC:US $ 498.63M 0.28M
Prestige Brands PBH:US $ 304.81M 103.71M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
United Therapeutics UTHR:US $ 2385.9M 68M
Zoetis ZTS:US $ 6682M 366M